Physician-Reported Use of GLP-1 Receptor Agonists in the UK

被引:0
|
作者
Curtis, Sarah
Jordan, Jessica B.
Boye, Kristina S.
Matza, Louis S.
Adetunji, Omolara
Martin, Sherry A.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1158-P
引用
收藏
页码:A298 / A298
页数:1
相关论文
共 50 条
  • [1] Physician perceptions of GLP-1 receptor agonists in the UK
    Matza, Louis S.
    Curtis, Sarah E.
    Jordan, Jessica B.
    Adetunji, Omolara
    Martin, Sherry A.
    Boye, Kristina S.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (05) : 857 - 864
  • [4] GLP-1 receptor agonists in NAFLD
    Petit, J. -M.
    Verges, B.
    [J]. DIABETES & METABOLISM, 2017, 43 : 2S28 - 2S33
  • [5] Emerging GLP-1 receptor agonists
    Lund, Asger
    Knop, Filip K.
    Vilsboll, Tina
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (04) : 607 - 618
  • [6] GLP-1 receptor agonists today
    Marre, Michel
    Penfornis, Alfred
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 (03) : 317 - 327
  • [7] The Future of the GLP-1 Receptor Agonists
    Hirsch, Irl B.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (15): : 1457 - 1458
  • [8] Positioning on GLP-1 receptor agonists
    Gimenez, Sergio
    Piskorz, Daniel
    Martinez Demaria, Diego
    Nanfara, Silvia
    Lorenzatti, Alberto
    Zapata, Gerardo
    Aguinaga Arrascue, Luis
    Perna, Eduardo
    [J]. REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2021, 50 : 4 - 10
  • [9] Risk of thyroid cancer with the use of GLP-1 receptor agonists
    Gouverneur, Amandine
    Penichon, Marine
    Garrel, Renaud
    Hillaire-Buys, Dominique
    Pariente, Antoine
    Faillie, Jean-Luc
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 330 - 330
  • [10] Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
    Seghieri, Marta
    Christensen, Alexander S.
    Andersen, Andreas
    Solini, Anna
    Knop, Filip K.
    Vilsboll, Tina
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2018, 9